Stockholm, Sweden · Founded 2017 · Privately Held (backing)
Developer of a clinical-stage pharmaceutical portfolio designed to treat inflammatory diseases by inhibiting pro-inflammatory pathways. Gesynta Pharma is based in Stockholm, Sweden and was founded in 2017. Its last reported valuation was $42.8 million in Dec 2021. It has raised $77.8 million.
Last reported valuation
$42.8M
Oct 2026
Priced at
—
Total raised
$77.8M
Last round
—
Team — not yet on record
No current team members for Gesynta Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Gesynta Pharma with a free account
·The complete investor list: 17 names
·Watch Gesynta Pharma: the Monday email on marks, rounds and moves
